Financials

News Discussions Technicals Seasonals

2496 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to WUHAN YZY BIOPHARMA CO. LTD. operating, investing, and financing activities

2496 free cash flow for H1 24 is -63.91 M HKD. For 2023, 2496 free cash flow was -209.11 M HKD and operating cash flow was -206.98 M HKD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—